Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kulandayan Subramanian"'
Autor:
Sneha Berry, Nicolas Giraldo, Peter Nguyen, Benjamin Green, Haiying Xu, Aleksandra Ogurtsova, Abha Soni, Farah Succaria, Daphne Wang, Charles Roberts, Julie Stein, Elizabeth Engle, Drew Pardoll, Robert Anders, Tricia Cottrell, Janis M. Taube, Ben Tran, Mark Voskoboynik, James Kuo, Yung-Lue Bang, Hyun-Cheo Chung, Myung-Ju Ahn, Sang-We Kim, Ayesh Perera, Daniel Freeman, Ikbel Achour, Raffaella Faggioni, Feng Xiao, Charles Ferte, Charlotte Lemech, Funda Meric-Bernstam, Theresa Werner, Stephen Hodi, Wells Messersmith, Nancy Lewis, Craig Talluto, Mirek Dostalek, Aiyang Tao, Sarah McWhirter, Damian Trujillo, Jason Luke, Chunxiao Xu, BoMarelli, Jin Qi, Guozhong Qin, Huakui Yu, Molly Jenkins, Kin-Ming Lo, Joern-Peter Halle, Yan Lan, Matthew Taylor, Nicholas Vogelzang, Allen Cohn, Daniel Stepan, Robert Shumaker, Corina Dutcus, Matthew Guo, Emmett Schmidt, Drew Rasco, Marcia Brose, Christopher Di Simone, Sharad Jain, Donald Richards, Carlos Encarnacion, James Mier, Jeongshin An, Yeun-yeoul Yang, Won-Hee Lee, Jinho Yang, Jong-kyu Kim, Hyun Goo Kim, Se Hyun Paek, Jun Woo Lee, Joohyun Woo, Jong Bin Kim, Hyungju Kwon, Woosung Lim, Nam Sun Paik, Yoon-Keun Kim, Byung-In Moon, Filip Janku, David Tan, Juan Martin-Liberal, Shunji Takahashi, Ravit Geva, Ayca Gucalp, Xueying Chen, Kulandayan Subramanian, Jennifer Mataraza, Jennifer Wheler, Philippe Bedard
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-11 (2019)
After publication of this supplement [1, 2], it was brought to our attention that due to an error authors were missing in the following abstracts. This has now been included in this correction.
Externí odkaz:
https://doaj.org/article/5e0fdcdf298e4148a8ad792b96d6446a
Autor:
Salvatore Siena, Vasileios Askoxylakis, Glenn Dranoff, Marc R. Pelletier, Lang Ho Lee, Lori A. Iaconis, Sarah M. Choi, Heidi A. Schoenfeld, Kulandayan Subramanian, Ping C. Mahling, Susan E. Cellitti, Alex Cortez, Yasutoshi Kuboki, Jaffer A. Ajani, Alessio Amatu, Toshihiko Doi, Sae-Won Han, Filip Janku
Immune-stimulator antibody conjugates (ISAC) combining tumor-targeting monoclonal antibodies with immunostimulatory agents allow targeted delivery of immune activators into tumors. NJH395 is a novel, first-in-class ISAC comprising a Toll‐like recep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7971b7d07116fc0c53b6de7673a36ee9
https://doi.org/10.1158/2326-6066.c.6551021.v1
https://doi.org/10.1158/2326-6066.c.6551021.v1
Autor:
Salvatore Siena, Vasileios Askoxylakis, Glenn Dranoff, Marc R. Pelletier, Lang Ho Lee, Lori A. Iaconis, Sarah M. Choi, Heidi A. Schoenfeld, Kulandayan Subramanian, Ping C. Mahling, Susan E. Cellitti, Alex Cortez, Yasutoshi Kuboki, Jaffer A. Ajani, Alessio Amatu, Toshihiko Doi, Sae-Won Han, Filip Janku
Supplementary Figure from Preclinical Characterization and Phase I Study of an Anti–HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ Malignancies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::704176b41c46a7157ecea1d47d7de480
https://doi.org/10.1158/2326-6066.22545746.v1
https://doi.org/10.1158/2326-6066.22545746.v1
Autor:
Salvatore Siena, Vasileios Askoxylakis, Glenn Dranoff, Marc R. Pelletier, Lang Ho Lee, Lori A. Iaconis, Sarah M. Choi, Heidi A. Schoenfeld, Kulandayan Subramanian, Ping C. Mahling, Susan E. Cellitti, Alex Cortez, Yasutoshi Kuboki, Jaffer A. Ajani, Alessio Amatu, Toshihiko Doi, Sae-Won Han, Filip Janku
Supplementary Data from Preclinical Characterization and Phase I Study of an Anti–HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ Malignancies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a5f94745c1462cb05163a0a0fdf5af8
https://doi.org/10.1158/2326-6066.22545749.v1
https://doi.org/10.1158/2326-6066.22545749.v1
Autor:
Filip Janku, Sae-Won Han, Toshihiko Doi, Alessio Amatu, Jaffer A. Ajani, Yasutoshi Kuboki, Alex Cortez, Susan E. Cellitti, Ping C. Mahling, Kulandayan Subramanian, Heidi A. Schoenfeld, Sarah M. Choi, Lori A. Iaconis, Lang Ho Lee, Marc R. Pelletier, Glenn Dranoff, Vasileios Askoxylakis, Salvatore Siena
Publikováno v:
Cancer immunology research. 10(12)
Immune-stimulator antibody conjugates (ISAC) combining tumor-targeting monoclonal antibodies with immunostimulatory agents allow targeted delivery of immune activators into tumors. NJH395 is a novel, first-in-class ISAC comprising a Toll-like recepto
Publikováno v:
Clinical Pharmacology & Therapeutics; Feb2023, Vol. 113 Issue 2, p212-217, 6p